Tag: Seqirus

Advanced Manufacturing

Vaccine maker CSL’s massive year, massive profits

Australia’s largest company by market capitalisation, biotechnology manufacturer CSL has powered ahead in the first half of the financial year reporting a net profit after tax up 44 per...

CSL to build $800m Melbourne vaccine facility

16 November 2020 | by Peter Roberts

Biotechnology giant CSL will spend more than $800 million building a new vaccine manufacturing plant at the Melbourne Airport Business Park, with operations expected to start in 2026. The...

Tag: Seqirus

Vaccine maker CSL’s massive year, massive profits

CSL to build $800m Melbourne vaccine facility

Guide

Categories

SUBSCRIPTION ENQUIRIES

Privacy

EDITORIAL CONTACT

COMMERCIAL CONTACT

Search Filters Clear All

Tag: Seqirus